NCT00095823 A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00095550 Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension Status COMPLETED Phase PHASE3
NCT00095394 Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension Status COMPLETED Phase PHASE3
NCT00095290 Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria Status COMPLETED Phase PHASE4
NCT00095238 Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) Status COMPLETED Phase PHASE3
NCT00095173 BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00095147 Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00095030 Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone Status COMPLETED Phase PHASE3
NCT00094991 Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00094653 MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma Status COMPLETED Phase PHASE3
NCT00086892 Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00084656 Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00084253 Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients Status COMPLETED Phase PHASE4
NCT00083720 Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy Status COMPLETED Phase PHASE2
NCT00082212 A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma Status TERMINATED Phase PHASE2
NCT00077233 FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Status TERMINATED Phase PHASE3
NCT00067782 A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy Status COMPLETED Phase PHASE3